Cargando…
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
Dexamethasone has antitumor activity in metastatic castration resistant prostate cancer (mCRPC). We aimed to investigate intravenous liposome‐encapsulated dexamethasone disodium phosphate (liposomal dexamethasone) administration in mCRPC patients. In this exploratory first‐in‐man study, patients in...
Autores principales: | Vrouwe, Josephina P. M., Kamerling, Ingrid M. C., van Esdonk, Michiel J., Metselaar, Josbert M., Stuurman, Frederik E., van der Pluijm, Gabri, Burggraaf, Jacobus, Osanto, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377443/ https://www.ncbi.nlm.nih.gov/pubmed/34414692 http://dx.doi.org/10.1002/prp2.845 |
Ejemplares similares
-
Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
por: Kroon, Jan, et al.
Publicado: (2015) -
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
por: Metselaar, Josbert, et al.
Publicado: (2023) -
The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption
por: Dijkmans, Anneke C., et al.
Publicado: (2019) -
Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
por: van Alem, Carla M. A., et al.
Publicado: (2021) -
Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments
por: Vrouwe, J.P.M., et al.
Publicado: (2021)